Daihan Pharmaceutical Co.,Ltd. (KOSDAQ:023910)
28,600
-500 (-1.72%)
Apr 2, 2026, 3:30 PM KST
12.60% (1Y)
| Market Cap | 168.17B +12.8% |
| Revenue (ttm) | 208.61B +2.2% |
| Net Income | 27.64B -18.1% |
| EPS | n/a |
| Shares Out | 5.88M |
| PE Ratio | 6.08 |
| Forward PE | 5.11 |
| Dividend | 900.00 (3.09%) |
| Ex-Dividend Date | Dec 29, 2025 |
| Volume | 16,107 |
| Average Volume | 12,493 |
| Open | 29,150 |
| Previous Close | 29,100 |
| Day's Range | 28,250 - 29,300 |
| 52-Week Range | 24,750 - 33,950 |
| Beta | 0.19 |
| RSI | 44.09 |
| Earnings Date | May 15, 2026 |